Viridian Therapeutics (VRDN) Q4 2022 Earnings

8MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1.13
-1
-0.86
-0.73

Details

Expected EPS
-0.73
Actual EPS
-1.13
Surprise EPS
-0.4
Surprise Percent
+54.79%

Description

Viridian Therapeutics (VRDN) has reported earnings of -1.13 per share for Q4 2022.

0 Comments

Share your thoughts